Home
OrbiMed Advisors IV, Director: ArriVent BioPharma AVBP Buy · Filed 24/01/31
Trade details
- Type
- Insider buy
- Amount
- $3,999,996
- Shares · price
- 222,222 sh · $18.00 a share
- Held after
- 1,513,664 sh
- Trade date
- 24/01/30
- Filed
- 24/01/31
- Days to filing
- 1 days
First buy since 2023
- Insiders buying this week
- 8 insiders
- Holding change
- +17.2%
ArriVent BioPharma trades, last 26 weeks
What else happened in ArriVent BioPharma around then
Filed or reported within 30 days of the trade day · 23/12/31~24/02/29OrbiMed Advisors IV's recent trades
- OrbiMed Advisors IV
BuyArriVent BioPharma
BuyArriVent BioPharma
AVBP
$4M
222,222 sh
$4M
Filed 24/01/31
Traded 24/01/30
- OrbiMed Advisors IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$1.4M
490,511 sh
$1.4M
Filed 23/05/08
Traded 23/05/05
- OrbiMed Advisors IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$1.4M
490,512 sh
$1.4M
Filed 23/05/08
Traded 23/05/05
- OrbiMed Advisors IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$860.7K
312,991 sh
$860.7K
Filed 23/05/08
Traded 23/05/04
- OrbiMed Advisors IV
BuyKinnate Biopharma
BuyKinnate Biopharma
KNTE
$229.5K
83,459 sh
$229.5K
Filed 23/05/08
Traded 23/05/04